How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?

Autor: Han, Ru, Gomez, Jorge A., de Veras, Bruna, Pinto, Thatiana, Guzman-Holst, Adriana, Nieto, Javier, van Oorschot, Désirée A. M.
Zdroj: Human Vaccines & Immunotherapeutics; 2023, Vol. 19 Issue 1, p1-14, 14p
Databáze: Complementary Index